StonvexLoading…
StonvexStonvexStonvexCore line items from TRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.48B | $7.26B | $6.79B | $6.63B |
Operating Income | $2.13B | $2.11B | $2.33B | $1.83B |
Net Income | $1.50B | $2.21B | $2.69B | $1.34B |
EPS (Diluted) | $3.33 | $4.89 | $5.80 | $2.75 |
Total Assets | $17.94B | $18.44B | $18.68B | $21.71B |
Total Liabilities | $6.03B | $6.43B | $7.62B | $9.83B |
Cash & Equivalents | $511.00M | $1.97B | $1.30B | $1.07B |
Free Cash Flow OCF − CapEx | $2.02B | $1.85B | $1.80B | $1.32B |
Shares Outstanding | Not available | Not available | Not available | Not available |